Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sells USD 743,436 in common shares

Bitget2026/09/28 22:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini reported sales of 3,708 common shares on Sept. 24-25, 2026.
Sales priced at USD 200 on Sept. 24 for 587 shares, USD 200.54 on Sept. 25 for 3,121 shares.
He exercised stock options for 3,121 shares at USD 33.62 on Sept. 25, 2026.
Directly held common shares totaled 39,765 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002124509-26-000012), on September 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sells USD 743,436 in common shares

You may also like

Crypto prices